The Malaysian market accounted for USD 3.76 billion in 2025.
Our projections place the Malaysia Infusion Services Market at USD 13.06 billion by 2033, reflecting an anticipated CAGR of 16.9% during the forecast period.
Urban private hospital growth is strengthening oncology infusion infrastructure, supported by rising middle-income healthcare spending and medical tourism inflows.
Ministry of Health disease burden data highlight increasing non-communicable disease prevalence, underpinning gradual biologic infusion capacity expansion.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]